Figure S3.
Treatment of stroma cells with JNIK1 inhibitors. (A–C) CellTiter-Glo assay of M2-10B4 stromal cells after 24 h of treatment with SP600125 (left), CC-930 (middle), and L-JNKi (right) inhibitors. (D–F) CellTiter-Glo assay of CD40L secreting cells after 24 h of treatment with SP600125 (left), CC-930 (middle), and L-JNKi (right) inhibitors (unpaired t test, *P < 0.05).

Treatment of stroma cells with JNIK1 inhibitors . (A–C) CellTiter-Glo assay of M2-10B4 stromal cells after 24 h of treatment with SP600125 (left), CC-930 (middle), and L-JNKi (right) inhibitors. (D–F) CellTiter-Glo assay of CD40L secreting cells after 24 h of treatment with SP600125 (left), CC-930 (middle), and L-JNKi (right) inhibitors (unpaired t test, *P < 0.05).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal